Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Shortening Timelines to Phase I Formulation

With micro-dosing technology, the number of process steps involved in taking a new drug into clinical trials can be reduced, enabling new drugs to enter the clinic more quickly and failed compounds to be weeded out earlier - resulting in valuable savings in clinical expenditure.

By David Edwards at Capsugel (March 2009)

Keywords: Drivers in critical path, automated micro-dosing, process development.

    View full article    |    Back to Ingredients, Formulations and Finishing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |